The date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended up to 01.08.2023 for both SSI and non SSI manufactured drugs.
Government of India
Ministry of Commerce and Industry
Department of Commerce
Directorate General of Foreign Trade
New Delhi
Public Notice No. 3/2023-DGFT | Dated the 3rd April, 2023
Subject: Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments along with maintaining the Parent-Child relationship in the levels of packaging and their movement in supply chain – Extension of date of implementation regarding.
F.No. 01/91/180/648/AM-09/EC/E-21052.—In exercise of the powers conferred under Paragraph 2.04 of the Foreign Trade Policy, 2015-20, as amended from time to time, the Director General of Foreign ‘Trade hereby amends Para 2.90A of Handbook of Procedure- 2015-20, as notified vide Public Notice No. 43/2015-20 dated 05.12,2017 read with Public Notice No. 52 / 2015-20 dated 05.01.2016, Public Notice No. 05/2015-20 dated 09.05.2018, Public Notice No. 43/20152020 dated 01.11.2018, Public Notice No. 16/2015- 2020 dated 04.07.2019, Public Notice No. 66/2015- 2020 dated 30.03.2020, Public Notice No. 16/2015-2020 dated 22.9.2020, Public Notice No. 46/2015-20 dated 30.03.2021 and Public Notice No. 01/2015-2020 dated 04.01.2022 on laying down the procedure for implementation of the Track and Trace system for export consignments of drug formulations.
2. In Para 2.90 A (vi) and (vii) of Handbook of Procedure – 2015-20 (as amended vide Public Notice No. 01/2015-2020 dated 04.01.2022), “31.3.2023” may be substituted by 01.08.2023″.
3. Effect of this Public Notice:
The date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended upto 01.08.2023 for both SSI and non SSI manufactured drugs.
(Santosh Kumar Sarangi)
Director General of Foreign Trade
Ex-officio Additional Secretary, Government of India
E-mail: dgft@nic.in
(Issued from F.No. 01/91/180/648/AM-09/EC/E-21052)
